Treatment patterns of gemcitabine-based chemotherapy in patients with de novo and recurrent advanced biliary tract cancer.

被引:0
|
作者
Dayyani, Farshid
Stirnadel-Farrant, Heide A.
Hu, Jenny
Lin, Yian
Kebede, Nehemiah
Valerio, Stephen J.
Ahn, Daniel H.
机构
[1] Univ Calif Irvine, Dept Med, Div Hematol Oncol, Orange, CA USA
[2] AstraZeneca, Cambridge, England
[3] AstraZeneca, Gaithersburg, MD USA
[4] AstraZeneca, South San Francisco, CA USA
[5] Mayo Clin, Div Med Oncol, Phoenix, AZ USA
关键词
281-318-6655; 130-544; 283-237-2581-144; 281-487; 261-566-148; 6; 3; 2; 1614; 3590; 176; 239; 54; 2018; 92; 1;
D O I
10.1200/JCO.2024.42.3_suppl.454
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:454 / 454
页数:1
相关论文
共 50 条
  • [21] Comorbidity, not age, is prognostic in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Sasahira, Naoki
    Tsujino, Takeshi
    Kogure, Hirofumi
    Yagioka, Hiroshi
    Yashima, Yoko
    Togawa, Osama
    Arizumi, Toshihiko
    Matsubara, Saburo
    Hirano, Kenji
    Tada, Minoru
    Omata, Masao
    Koike, Kazuhiko
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 (03) : 252 - 259
  • [22] GEMCITABINE AS A SALVAGE CHEMOTHERAPY FOR RECURRENT PATIENTS WITH OVARIAN CANCER.
    Ohara, T.
    Kondo, A.
    Nakagawa, Y.
    Yoshida, A.
    Yoshida, A.
    Yoshioka, N.
    Tozawa, A.
    Suzuki, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [23] Adjuvant gemcitabine-based chemotherapy for biliary tract cancer: Pooled analysis of the BCAT and PRODIGE-12 studies
    Edeline, J.
    Hirano, S.
    Bertaut, A.
    Konishi, M.
    Benabdelghani, M.
    Uesaka, K.
    Watelet, J.
    Ohtsuka, M.
    Hammel, P.
    Kaneoka, Y.
    Joly, J-P.
    Yamamoto, M.
    Jouffroy, C.
    Ambo, Y.
    Louvet, C.
    Ando, M.
    Malka, D.
    Nagino, M.
    Phelip, J. M.
    Ebata, T.
    ANNALS OF ONCOLOGY, 2020, 31 : S262 - S262
  • [24] Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study
    Kim, Mi-Jung
    Oh, Do-Youn
    Lee, Se-Hoon
    Kim, Dong-Wan
    Im, Seock-Ah
    Kim, Tae-You
    Heo, Dae Seog
    Bang, Yung-Jue
    BMC CANCER, 2008, 8 (1)
  • [25] Patterns of care and treatment outcomes in older patients with biliary tract cancer.
    Horgan, Anne M.
    McNamara, Mairead G.
    Aneja, Priya
    Le, Lisa W.
    McKeever, Elizabeth
    Knox, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [26] Timing of chemotherapy-induced neutropenia: the prognostic factor in advanced pancreatic cancer patients treated with gemcitabine / gemcitabine-based chemotherapy
    Chen, Yang
    Shi, Yan
    Yan, Huan
    Wang, Yan Rong
    Dai, Guang Hai
    ONCOTARGET, 2017, 8 (39) : 66593 - 66600
  • [27] Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer
    J Harder
    B Riecken
    O Kummer
    C Lohrmann
    F Otto
    H Usadel
    M Geissler
    O Opitz
    H Henß
    British Journal of Cancer, 2006, 95 : 848 - 852
  • [28] Treatment of metastatic and/or unresectable pancreatic cancer with gemcitabine-based chemotherapy
    Samelis, GF
    Zografos, G
    Areovimata, A
    Kitsou, V
    Papakostas, P
    ANNALS OF ONCOLOGY, 2005, 16 : 324 - 324
  • [29] Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer
    Harder, J.
    Riecken, B.
    Kummer, O.
    Lohrmann, C.
    Otto, F.
    Usadel, H.
    Geissler, M.
    Opitz, O.
    Henss, H.
    BRITISH JOURNAL OF CANCER, 2006, 95 (07) : 848 - 852
  • [30] Establishment of a Pretreatment Nomogram to Predict the 6-Month Mortality Rate of Patients with Advanced Biliary Tract Cancers Undergoing Gemcitabine-Based Chemotherapy
    Wu, Chiao-En
    Huang, Wen-Kuan
    Chou, Wen-Chi
    Hsieh, Chia-Hsun
    Chang, John Wen-Cheng
    Lin, Cheng-Yu
    Yeh, Chun-Nan
    Chen, Jen-Shi
    CANCERS, 2021, 13 (13)